What to expect when you take Levaquin and have Disease progression?

Do you take Levaquin and have Disease progression? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 22, 2018

7,513 reports have been studied.


Females aged 50 to 59 :

4,777 related reports were analyzed:

Most common symptoms:

Back pain
  • 5.44% for females aged 50 (±5) who take Levaquin
Chest pain
  • 5.02% for females aged 50 (±5) who take Levaquin
Depression
  • 6.34% for females aged 50 (±5) who take Levaquin
Diarrhea
  • 7.2% for females aged 50 (±5) who take Levaquin
Dizziness
  • 6.66% for females aged 50 (±5) who take Levaquin
Dyspnea (difficult or laboured breathing)
  • 8.35% for females aged 50 (±5) who take Levaquin
Fatigue (feeling of tiredness)
  • 8.46% for females aged 50 (±5) who take Levaquin
Fever
  • 6.07% for females aged 50 (±5) who take Levaquin
Gait disturbance
  • 5.36% for females aged 50 (±5) who take Levaquin
Headache (pain in head)
  • 6.03% for females aged 50 (±5) who take Levaquin
Hypoaesthesia (reduced sense of touch or sensation)
  • 6.8% for females aged 50 (±5) who take Levaquin
Insomnia (sleeplessness)
  • 6.57% for females aged 50 (±5) who take Levaquin
Joint pain
  • 15.24% for females aged 50 (±5) who take Levaquin
Muscle aches (muscle pain)
  • 5.34% for females aged 50 (±5) who take Levaquin
Nausea (feeling of having an urge to vomit)
  • 9.76% for females aged 50 (±5) who take Levaquin
Neuropathy peripheral (surface nerve damage)
  • 5.65% for females aged 50 (±5) who take Levaquin
Oedema peripheral (superficial swelling)
  • 5.95% for females aged 50 (±5) who take Levaquin
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  • 5.44% for females aged 50 (±5) who take Levaquin
Pain
  • 12.77% for females aged 50 (±5) who take Levaquin
Pain in extremity
  • 9.84% for females aged 50 (±5) who take Levaquin
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • 5.9% for females aged 50 (±5) who take Levaquin
Rashes (redness)
  • 6.2% for females aged 50 (±5) who take Levaquin
Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  • 5.9% for females aged 50 (±5) who take Levaquin
Stress and anxiety
  • 9.42% for females aged 50 (±5) who take Levaquin
Tendon rupture (tear of tendon)
  • 7.37% for females aged 50 (±5) who take Levaquin
Tendonitis (a condition that causes pain and swelling of tendons)
  • 8.48% for females aged 50 (±5) who take Levaquin
Weakness
  • 10.82% for females aged 50 (±5) who take Levaquin

Most common co-existing conditions:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  • 5.71% for females aged 50 (±5) who take Levaquin
Pain
  • 5.88% for females aged 50 (±5) who take Levaquin
Urinary tract infection
  • 6.47% for females aged 50 (±5) who take Levaquin
back to top

Males aged 50 to 59 :

2,736 related reports were analyzed:

Most common symptoms:

Anaemia (lack of blood)
  • 5.26% for males aged 50 (±5) who take Levaquin
Back pain
  • 5.3% for males aged 50 (±5) who take Levaquin
Depression
  • 6.1% for males aged 50 (±5) who take Levaquin
Diarrhea
  • 5.19% for males aged 50 (±5) who take Levaquin
Dizziness
  • 5.08% for males aged 50 (±5) who take Levaquin
Dyspnea (difficult or laboured breathing)
  • 6.98% for males aged 50 (±5) who take Levaquin
Fatigue (feeling of tiredness)
  • 8.04% for males aged 50 (±5) who take Levaquin
Fever
  • 7.2% for males aged 50 (±5) who take Levaquin
Headache (pain in head)
  • 5.19% for males aged 50 (±5) who take Levaquin
Insomnia (sleeplessness)
  • 5.19% for males aged 50 (±5) who take Levaquin
Joint pain
  • 8.77% for males aged 50 (±5) who take Levaquin
Nausea (feeling of having an urge to vomit)
  • 7.38% for males aged 50 (±5) who take Levaquin
Neuropathy peripheral (surface nerve damage)
  • 5.77% for males aged 50 (±5) who take Levaquin
Oedema peripheral (superficial swelling)
  • 5.34% for males aged 50 (±5) who take Levaquin
Pain
  • 9.43% for males aged 50 (±5) who take Levaquin
Pain in extremity
  • 6.21% for males aged 50 (±5) who take Levaquin
Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  • 6.25% for males aged 50 (±5) who take Levaquin
Stress and anxiety
  • 8.7% for males aged 50 (±5) who take Levaquin
Tendon rupture (tear of tendon)
  • 9.83% for males aged 50 (±5) who take Levaquin
Tendonitis (a condition that causes pain and swelling of tendons)
  • 7.38% for males aged 50 (±5) who take Levaquin
Weakness
  • 7.38% for males aged 50 (±5) who take Levaquin

Most common co-existing conditions:

Multiple myeloma (cancer of the plasma cells)
  • 6.83% for males aged 50 (±5) who take Levaquin
Pain
  • 6.73% for males aged 50 (±5) who take Levaquin
back to top

Related studies

levaquin

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. (latest outcomes from Levaquin 41,532 users)

disease progression

Disease progression has been reported by people with multiple myeloma, renal cell carcinoma, breast cancer, breast cancer metastatic, colon cancer (latest reports from 51,074 Disease progression patients).

Levaquin and Disease progression

Related publications that referenced our studies


Analysis tools (to study 615 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Levaquin, Disease progression

Recent updates

General studies
Active Support Groups
Recent Predictions
Care Guides wanted

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.